Home
World's First Fully Automated AI Scientist Robin Disrupts Traditional Research in Just Two Hours

FutureHouse, a non-profit research organization, published a landmark study in Nature, revealing Robin—the world’s first multi-agent AI system capable of full closed-loop automation in scientific discovery. In under two hours, Robin accomplished work that typically requires human scientists nearly four months, or roughly 900 hours.
A tireless research team
Robin’s innovation stems from its integration of three specialized AI agents, linking hypothesis generation to validation. The "Crow" agent rapidly scans extensive literature to formulate experimental strategies, the "Falcon" agent performs in-depth evaluations, and the "Finch" agent handles data analysis, independently writing code and generating rigorous statistical charts.
In a practical test focused on dry age-related macular degeneration (dAMD), Robin processed hundreds of documents in just thirty minutes. It accurately identified the core pathogenic mechanism—impaired phagocytic function of retinal pigment epithelial cells—and precisely screened multiple potential drugs from a large library, significantly accelerating the early stages of drug development.
Autonomous pharmacological insights and new pathways
Following in vitro cell experiments by human scientists based on Robin’s candidate list, "Ripasudil," a glaucoma drug, was confirmed to have strong repurposing potential. Remarkably, when analyzing experimental data, Robin autonomously designed an RNA sequencing (RNA-seq) plan, successfully uncovering the drug’s underlying pharmacological mechanisms.
During data analysis, Robin also identified a previously overlooked clue: significant upregulation of the "ABCA1" gene, revealing a new avenue for targeted therapies for this eye disease. This unprecedented efficiency and insight signal the start of a new era in AI-driven scientific discovery.
Related article
ByteDance’s Seed launches global campus drive, offering virtual shares to win top large model talent
In the competitive landscape of large language models, securing top-tier talent remains the most critical strategic asset.On April 1st, ByteDance announced the launch of its Seed global campus recruitment initiative, part of its large model talent de
Suno to Watermark Songs Amid Legal Battles
Suno, the platform enabling users to generate AI-created music, has unveiled new features to label platform-produced tracks, restrict downloads, and update community standards to curb unauthorized replicas. These updates arrive as Suno confronts mult
Musk Admits Grok Build Leaked User Code, Promises to Erase All Historical Data
Elon Musk directly addressed the privacy controversy surrounding Grok Build, beginning with a simple "True" to confirm the incident's validity. He pledged that all user data previously uploaded to SpaceXAI would be permanently erased, stating, "not a
Related Special Topic Recommendations
Comments (0)
0/500

FutureHouse, a non-profit research organization, published a landmark study in Nature, revealing Robin—the world’s first multi-agent AI system capable of full closed-loop automation in scientific discovery. In under two hours, Robin accomplished work that typically requires human scientists nearly four months, or roughly 900 hours.
A tireless research team
Robin’s innovation stems from its integration of three specialized AI agents, linking hypothesis generation to validation. The "Crow" agent rapidly scans extensive literature to formulate experimental strategies, the "Falcon" agent performs in-depth evaluations, and the "Finch" agent handles data analysis, independently writing code and generating rigorous statistical charts.
In a practical test focused on dry age-related macular degeneration (dAMD), Robin processed hundreds of documents in just thirty minutes. It accurately identified the core pathogenic mechanism—impaired phagocytic function of retinal pigment epithelial cells—and precisely screened multiple potential drugs from a large library, significantly accelerating the early stages of drug development.
Autonomous pharmacological insights and new pathways
Following in vitro cell experiments by human scientists based on Robin’s candidate list, "Ripasudil," a glaucoma drug, was confirmed to have strong repurposing potential. Remarkably, when analyzing experimental data, Robin autonomously designed an RNA sequencing (RNA-seq) plan, successfully uncovering the drug’s underlying pharmacological mechanisms.
During data analysis, Robin also identified a previously overlooked clue: significant upregulation of the "ABCA1" gene, revealing a new avenue for targeted therapies for this eye disease. This unprecedented efficiency and insight signal the start of a new era in AI-driven scientific discovery.
ByteDance’s Seed launches global campus drive, offering virtual shares to win top large model talent
In the competitive landscape of large language models, securing top-tier talent remains the most critical strategic asset.On April 1st, ByteDance announced the launch of its Seed global campus recruitment initiative, part of its large model talent de
Suno to Watermark Songs Amid Legal Battles
Suno, the platform enabling users to generate AI-created music, has unveiled new features to label platform-produced tracks, restrict downloads, and update community standards to curb unauthorized replicas. These updates arrive as Suno confronts mult
Musk Admits Grok Build Leaked User Code, Promises to Erase All Historical Data
Elon Musk directly addressed the privacy controversy surrounding Grok Build, beginning with a simple "True" to confirm the incident's validity. He pledged that all user data previously uploaded to SpaceXAI would be permanently erased, stating, "not a











